Get it on Google Play

BioCryst Pharmaceuticals (BCRX) Enter Agreement with Green Cross to Develop and Commericalize Peramivir

June 14, 2006 7:15 AM EDT Send to a Friend
BioCryst Pharmaceuticals (Nasdaq: BCRX) announced an agreement with Green Cross Corporation, South Korea for the development and commercialization in Korea ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login